1. S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMA. (23rd June 2022) Authors: Pirosa, M. C.; Bruscaggin, A.; Terzi di Bergamo, L.; Salehi, M.; Pini, K.; Spina, V.; Bocchetta, S.; Condoluci, A.; Forestieri, G.; Piffaretti, D.; Marques De Almeida, J.; Annunziata, S.; Bergesio, F.; Borsatti, E.; Bulian, P.; Chauvie, S.; Marco, C.; Martina, D. T.; Bernhard, G.; Kurlapski, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗